Actavis (NYSE: ACT) reported Q2 EPS of $3.42, $0.06 better than the analyst estimate of $3.36. Revenue for the quarter came in at $2.67 billion versus the consensus estimate of $2.55 billion.

Actavis now sees FY2014 EPS of $13.02 - $13.32, versus the consensus of $13.73.

Actavis sees FY2015 EPS of $15.60 - $16.80, versus the consensus of $16.61.

For earnings history and earnings-related data on Actavis (ACT) click here.